Membership Update – December 2012/January 2013 BioNJ welcomes Marke Communications as a new Diamond Members for 2012/2013: Marke Communications Marke Communications is a full-service integrated marketing communications agency that has been in business for over 30 years. Our success is grounded in sound strategy, engaging creative and in the alliance we build with our clients. We are flexible and innovative with deep experience in healthcare marketing that allows us to understand the critical issues and regulatory changes facing today’s pharmaceutical industry. Headquartered on Fifth Avenue in New York City, we are keenly aware of what it takes to develop and implement the right strategic marketing programs utilizing integrated tactics that deliver results. Our unique structure allows us to conform to our clients’ needs with a unique combination of strategic insight and creative firepower. We invite you to visit our diverse portfolio at www.marke.com. BioNJ welcomes Advanced Pharmaceuticals, FluidDA, Geistlich Pharma, and S1Biopharma as new Core Members for 2012/2013: Advanced Pharmaceuticals, LLC Advanced Pharmaceuticals, LLC, located in Plainsboro is an innovative biotechnology company focused on the development of a drug for a rare neurological disease known as Krabbe disease. It has also been working on the development of a diagnostic biomarker for early detection of cancers, especially head and neck cancer and prostate cancer. Advanced Pharmaceuticals, LLC was founded in early 2010 by Dr. Hossen Mahmud who is the Owner and President of the company. His wife, Amina Mahmud, is a Co-owner and Managing Director of the company. FluidDA, Inc. FluidDA develops Functional Respiratory Imaging (FRI) Applications based upon CT analysis and Computational Functional Dynamics – CFD – methodology to accelerate Clinical Research for major research institutions, medical device companies and pharmaceutical companies. FluidDA’s set of repeatable measurements of lung structure and function is a novel Functional Respiratory Imaging Biomarker for diagnosis, staging and treatment of major lung disease. FluidDA is an established leader in quantitative image analysis for COPD, emphysema and asthma. FluidDA’s mission is to establish lung quantitative CT/CFD methods in the Clinical Research domain. More information on: www.FluidDA.com . Geistlich Pharma North America, Inc. Geistlich Pharma is the global leader in regenerative medicine in dental and oral-maxillofacial surgery with biomaterials targeted for bone and soft tissue regeneration. The company's 1 expertise in collagens extends to matrices for bone and cartilage regeneration in orthopedics, trauma and sports medicine. Geistlich Pharma also has a portfolio of proprietary pharmaceuticals and OTC products. Based in Switzerland, the company has a 160 year history of science based, high quality innovation. More information can be found at: www.geistlich-pharma.com S1Biopharma S1 Biopharma is a clinical stage biopharmaceutical company specializing in the discovery, development, and commercialization of drug therapies for Hypoactive Sexual Desire Disorder (HSDD) and related Sexual Dysfunctions. BioNJ welcomes Bench International, Biotrial, ECMB, MPI Research, The Tustin Group and Yankee Public Relations as new Associate Members for 2012/2013: Bench International Bench International is a global Women’s Business Enterprise (WBENC)-certified retained executive recruiting and consulting firm serving the life sciences sector exclusively since 1974. We pride ourselves as being one of the top executive recruitment providers for the sector, with a team that is deeply experienced and accomplished and has the content knowledge and expertise to translate and meet our clients’ needs and expectations for executive talent. Our vision, simply put, is to make life-changing placements so our clients can change lives. Bench International is headquartered in Los Angeles, California, with hubs in New York, the United Kingdom, Switzerland and Australia. Biotrial Founded in 1989, Biotrial is a leading CRO specializing in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalytical analysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing. Based in France, Belgium, the United Kingdom, Canada and the United States, Biotrial performs hundreds of studies a year and offers tailor-made solutions to Biotech and Pharmaceutical companies. In the past year Biotrial has expanded its French Phase I Units in Paris and Rennes, has extended its state-of-the-art Non-Clinical facilities in Rennes, and has announced the location of the new 100-bed Phase I Clinic in Newark, NJ. Biotrial has recently reinforced its expertise in neurocognitive assessments and sleep quality evaluation through the acquisition of Forenap’s Medical & Scientific expertise and PD systems. At the end of 2012, Biotrial extended its service line to include Bioanalytical analysis with the acquisition of a Bioanalytical laboratory in Laval, Quebec, Canada. For more information visit us at www.biotrial.com ECBM ECBM is an Insurance Brokerage and Consulting firm providing strong employee benefit and risk management through strategic consulting since 1970. A privately held firm, we have grown significantly with our long-term focus, providing innovative solutions to our clients. ECBM understands our client’s business and effectively navigates their ever-changing environment. 2 No matter the size of the group, we offer a cost‐reduction process which will improve your programs. We have set standards that ensure professional delivery of the services allowing us to consistently exceed client expectations. Our preferred remuneration is directly negotiated fees. We welcome the opportunity to assist members. ECBM - Effective Cost Based Management. MPI Research Our mission is to partner with biopharmaceutical and medical device companies globally to provide best-in-class, early-stage drug development services which ultimately results in safer, more efficacious products for the world. Our vision is to be recognized as the leading provider of early-stage drug development services through integrity, dedication, innovation, and focus with and among our Employees and our Sponsors. The Tustin Group NJ The Tustin Group has been providing advanced HVACR mechanical system solutions for commercial, institutional and industrial customers in the Delaware Valley, Lehigh Valley and Southern New Jersey for over 20 years. Whether it is to maintain, upgrade or re-design your HVACR mechanical, building automation or water management system, you can depend on the Tustin Group’s expertise for accurate diagnostics, cost-effective solutions, and expertly trained sales and service professionals. Yankee Public Relations Yankee Public Relations has over 25 years of experience leading proactive public relations and marketing communications initiatives for companies and organizations in the biopharmaceutical, healthcare and finance industries. We enable brand conscious clients of all sizes to achieve their business objectives through creative, multi-tiered communications initiatives. Yankee PR is a boutique communications firm that provides personalized service to clients and we take great pride in quickly responding to client needs. Yankee PR provides value-added communications services without the bureaucracy of larger firms. Public relations is a 24-hour, seven day week business and our commitment to clients illustrates this philosophy. BioNJ thanks Buchanan Ingersoll & Rooney PC and Pfizer, Inc. renewing as Platinum Members for 2013: Buchanan Ingersoll & Rooney PC Buchanan Ingersoll & Rooney PC has more than 450 attorneys and government relations professionals. The firm's bicoastal reach provides clients with nationwide access to all of our professional and their respective areas of experience. Our attorneys have deep experience in the life sciences industries, in areas such as pharmaceuticals, biotechnology, medical devices, medical foods and dietary supplements. Other industries that we serve include financial services, energy, entertainment and media, real estate, national security, natural resources and technology. With regard to the biotechnology industry, our lawyers and professionals are particularly focused on helping clients with U.S. Food and Drug Administration (FDA) and regulatory strategy; Research and Development, lawful marketing and sale of FDA-regulated products, capital formation and corporate finance, intellectual property and patent prosecution; licensing, collaboration and strategic alliances; government relations; and medical coverage and reimbursement. 3 We are dedicated to building a deep understanding of our clients, their businesses and their industries. The proof of our commitment to client service is in what is said about us. Buchanan was recently named on the "Client Service A-Team" for the eighth year in a row in an independent survey conducted by national market research and management consulting firm BTI. The survey consisted of corporate counsel at large and Fortune 1,000 companies. Pfizer Inc Pfizer Inc: Working together for a healthier world™ At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of